|
|
Managing Director - Menlo Park, California
|
 |
Doug Foster is a founder and Managing Director of Longitude Capital. He focuses on investments in both
private and public medical device companies for the fund.
From 2004 to 2006, Mr. Foster was a Vice President of Pequot Ventures where he worked in the life
sciences practice. Prior to Pequot Ventures, he worked for Pequot Capital Management's Scout Fund,
where he
managed publicly-traded equity investments across all sectors of the life sciences industry. Mr. Foster
has also worked at Novo Nordisk, a pharmaceutical company specializing in treatments of metabolic
disorders, including diabetes. He began his life sciences industry career as an Equity Research
Associate at Robertson, Stephens & Company in San Francisco.
He is or has been involved with the team’s investments in Alphatec (NASDAQ: ATEC), AqueSys, NxStage Medical (Nasdaq: NXTM), PixelOptics,
and Solta Medical (NASDAQ: SLTM), as well as Acufocus and Facet Solutions (acquired).
Mr. Foster holds an M.B.A. from the Graduate School of Business at Stanford University and a B.A. from Yale
University.
|
|
|
|
